Cargando…

An Overview of Bimekizumab for the Treatment of Psoriatic Arthritis: The Evidence so Far

Psoriatic arthritis is a complex and heterogeneous disease with potential significant disability and impaired quality of life. Although in the last decades new treatment options have led to a better management of this disease, there are still significant unmet therapeutic needs. Dual inhibitor antib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliveira, Daniel G, Faria, Raquel, Torres, Tiago
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955739/ https://www.ncbi.nlm.nih.gov/pubmed/33727793 http://dx.doi.org/10.2147/DDDT.S267405

Ejemplares similares

Deucravacitinib for the treatment of psoriatic arthritis: the evidence so far
por: Martins, Ana, et al.
Publicado: (2023)

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential
por: Chiricozzi, Andrea, et al.
Publicado: (2019)

Bimekizumab: the new drug in the biologics armamentarium for psoriasis
por: Freitas, Egídio, et al.
Publicado: (2021)

Review of bimekizumab in the treatment of psoriasis
por: Koppu, Sindhuja, et al.
Publicado: (2022)

Upadacitinib for the treatment of psoriatic arthritis
por: Fonseca, Diogo, et al.
Publicado: (2023)

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential [Corrigendum]
Publicado: (2019)

Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE
por: Mease, Philip J, et al.
Publicado: (2022)

Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge
por: Ruggiero, Angelo, et al.
Publicado: (2022)

Bimekizumab for plaque psoriasis
Publicado: (2022)

Bimekizumab in the Treatment of Plaque Psoriasis: Focus on Patient Selection and Perspectives
por: Camiña-Conforto, Gemma, et al.
Publicado: (2023)

The impact of mammographic screening on breast cancer mortality: overview of the evidence so far
por: Gabe, R, et al.
Publicado: (2004)

Local Treatment of Metastatic Prostate Cancer: What is the Evidence So Far?
por: Leonel Almeida, Pedro, et al.
Publicado: (2018)

Treatment Armamentarium of COVID-19: Evolving Strategies and Evidence So Far
por: Dhampalwar, Swapnil, et al.
Publicado: (2020)

An overview of psoriatic arthritis – epidemiology, clinical features, pathophysiology and novel treatment targets
por: Kerschbaumer, Andreas, et al.
Publicado: (2016)

What makes psoriatic and rheumatoid arthritis so different?
por: Veale, Douglas James, et al.
Publicado: (2015)

HIV and neoplasms: What do we know so far?
por: de Souza, Thais Faria, et al.
Publicado: (2023)

Inflammatory bowel disease induced by bimekizumab
por: Wietrzykowska-Grishanovich, Dominika, et al.
Publicado: (2022)

An Overview of Head and Neck Tumor Reirradiation: What Has Been Achieved So Far?
por: Gordon, Konstantin, et al.
Publicado: (2023)

What have we learned so far from the sex/gender issue in heart failure? An overview of current evidence
por: Arcopinto, Michele, et al.
Publicado: (2022)

Vitamin D status and peripheral arterial disease: evidence so far
por: Chua, GT, et al.
Publicado: (2011)

Treatment guidelines in psoriatic arthritis
por: Ogdie, Alexis, et al.
Publicado: (2020)

Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study
por: Ritchlin, Christopher T, et al.
Publicado: (2023)

Overview of the molecular determinants contributing to the expression of Psoriasis and Psoriatic Arthritis phenotypes
por: Caputo, Valerio, et al.
Publicado: (2020)

Spotlight on afatinib and its potential in the treatment of squamous cell lung cancer: the evidence so far
por: Xu, Yijun, et al.
Publicado: (2016)

Human Carcinogens So Far Identified
por: Tomatis, Lorenzo, et al.
Publicado: (1989)

Safety and Efficacy of Bimekizumab in Patients With Active Psoriatic Arthritis: Three‐Year Results From a Phase IIb Randomized Controlled Trial and Its Open‐Label Extension Study
por: Coates, Laura C., et al.
Publicado: (2022)

Safe and Effective Subcutaneous Self-Injection of Bimekizumab with Safety Syringe and Auto-Injector Devices: Results from a Multicenter, Randomized, Open-Label Study in Patients with Psoriatic Arthritis
por: Kivitz, Alan, et al.
Publicado: (2023)

Understanding gastrointestinal perfusion in critical care: so near, and yet so far
por: Ackland, Gareth, et al.
Publicado: (2000)

Obesity genes: so close and yet so far...
por: Pomp, Daniel, et al.
Publicado: (2008)

Deucravacitinib for the Treatment of Psoriatic Disease
por: Lé, Ana Maria, et al.
Publicado: (2022)

Diet in the Treatment of Epilepsy: What We Know So Far
por: Verrotti, Alberto, et al.
Publicado: (2020)

Psoriatic arthritis
por: Ocampo D, Vanessa, et al.
Publicado: (2019)

Neutrophils and COVID-19: The road so far
por: Cavalcante-Silva, Luiz Henrique Agra, et al.
Publicado: (2021)

And so to the far north
Publicado: (1978)

Mankind so far
por: Howells, W. W. (William White), 1908-
Publicado: (1945)

Mankind so far
por: Howells, William White 1908-
Publicado: (1947)

The journey so far
por: Ng, KH, et al.
Publicado: (2008)

The journey so far…
por: Gopikrishna, Velayutham
Publicado: (2010)

Nail Psoriasis: The Journey So Far
por: Dogra, Alka, et al.
Publicado: (2014)

Infliximab (Remicade) in the treatment of psoriatic arthritis
por: Mease, Philip
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_ga14ksil7sdfeq7goi3lo1tp83